| 0 |
BCG RELATED CYSTITIS |
8 |
0.4000 |
| 1 |
SHORT STATURE |
30 |
0.1145 |
| 2 |
IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY |
19 |
0.1092 |
| 3 |
RETICULOENDOTHELIAL SYSTEM STIMULATED |
1 |
0.1000 |
| 4 |
SPINAL INSTABILITY |
25 |
0.0984 |
| 5 |
ATLANTOAXIAL INSTABILITY |
9 |
0.0811 |
| 6 |
RETINAL ANOMALY CONGENITAL |
2 |
0.0800 |
| 7 |
IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME |
8 |
0.0530 |
| 8 |
OESOPHAGOMEDIASTINAL FISTULA |
1 |
0.0500 |
| 9 |
NEURONAL NEUROPATHY |
1 |
0.0476 |
| 10 |
SIGMOID SINUS THROMBOSIS |
2 |
0.0303 |
| 11 |
LYMPHODEPLETION |
1 |
0.0294 |
| 12 |
MENINGITIS CANDIDA |
2 |
0.0286 |
| 13 |
ACHROMOBACTER INFECTION |
3 |
0.0250 |
| 14 |
PANCREATIC FIBROSIS |
1 |
0.0196 |
| 15 |
CYSTITIS VIRAL |
7 |
0.0183 |
| 16 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
5 |
0.0176 |
| 17 |
RELAPSING FEVER |
5 |
0.0173 |
| 18 |
NASAL FLARING |
2 |
0.0149 |
| 19 |
INTESTINAL MUCOSAL TEAR |
1 |
0.0141 |
| 20 |
STEATOHEPATITIS |
7 |
0.0131 |
| 21 |
HEPATIC INFECTION BACTERIAL |
1 |
0.0128 |
| 22 |
DISSEMINATED VARICELLA ZOSTER VACCINE VIRUS INFECTION |
1 |
0.0127 |
| 23 |
SPINAL CORD OPERATION |
2 |
0.0105 |
| 24 |
POEMS SYNDROME |
1 |
0.0095 |
| 25 |
PROPIONIBACTERIUM INFECTION |
1 |
0.0093 |
| 26 |
CUSHINGOID |
30 |
0.0093 |
| 27 |
ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD |
1 |
0.0091 |
| 28 |
PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA |
1 |
0.0085 |
| 29 |
CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME |
1 |
0.0081 |
| 30 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
47 |
0.0079 |
| 31 |
PURPURA FULMINANS |
2 |
0.0079 |
| 32 |
PARANEOPLASTIC PEMPHIGUS |
1 |
0.0077 |
| 33 |
STENOTROPHOMONAS TEST POSITIVE |
1 |
0.0075 |
| 34 |
PNEUMONIA ACINETOBACTER |
1 |
0.0073 |
| 35 |
ADENOVIRUS REACTIVATION |
1 |
0.0069 |
| 36 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
9 |
0.0068 |
| 37 |
RETINOPATHY HYPERTENSIVE |
2 |
0.0066 |
| 38 |
OESOPHAGOBRONCHIAL FISTULA |
1 |
0.0066 |
| 39 |
VASCULAR COMPRESSION |
2 |
0.0063 |
| 40 |
GROWTH RETARDATION |
18 |
0.0061 |
| 41 |
DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV |
2 |
0.0061 |
| 42 |
INTERLEUKIN LEVEL INCREASED |
3 |
0.0054 |
| 43 |
ACINETOBACTER BACTERAEMIA |
1 |
0.0053 |
| 44 |
ENGRAFTMENT SYNDROME |
3 |
0.0051 |
| 45 |
PULSE PRESSURE INCREASED |
1 |
0.0048 |
| 46 |
CHLOROMA |
2 |
0.0047 |
| 47 |
ENTEROCOCCAL BACTERAEMIA |
5 |
0.0047 |
| 48 |
OSTEOPOROTIC FRACTURE |
9 |
0.0047 |
| 49 |
HYPERFERRITINAEMIA |
2 |
0.0046 |
| 50 |
ENDOTHELIAL DYSFUNCTION |
1 |
0.0043 |
| 51 |
EUSTACHIAN TUBE DISORDER |
1 |
0.0042 |
| 52 |
JEJUNAL PERFORATION |
1 |
0.0041 |
| 53 |
B-CELL APLASIA |
1 |
0.0039 |
| 54 |
CYTOTOXIC OEDEMA |
1 |
0.0038 |
| 55 |
HAEMOSIDEROSIS |
1 |
0.0037 |
| 56 |
LYMPHOCYTE ADOPTIVE THERAPY |
1 |
0.0036 |
| 57 |
BLOOD FIBRINOGEN DECREASED |
4 |
0.0035 |
| 58 |
BK VIRUS INFECTION |
11 |
0.0033 |
| 59 |
CYTOKINE RELEASE SYNDROME |
60 |
0.0030 |
| 60 |
OXYGEN SATURATION INCREASED |
1 |
0.0029 |
| 61 |
OSTEOLYSIS |
6 |
0.0029 |
| 62 |
CYTOKINE STORM |
2 |
0.0029 |
| 63 |
BASAL GANGLIA INFARCTION |
1 |
0.0029 |
| 64 |
JUVENILE IDIOPATHIC ARTHRITIS |
7 |
0.0029 |
| 65 |
POLYOMAVIRUS VIRAEMIA |
3 |
0.0028 |
| 66 |
HERPES ZOSTER MENINGOENCEPHALITIS |
1 |
0.0028 |
| 67 |
LYMPHADENOPATHY MEDIASTINAL |
5 |
0.0026 |
| 68 |
RHINOVIRUS INFECTION |
10 |
0.0026 |
| 69 |
CRITICAL ILLNESS |
2 |
0.0026 |
| 70 |
PARVOVIRUS INFECTION |
1 |
0.0025 |
| 71 |
PERICARDITIS CONSTRICTIVE |
1 |
0.0024 |
| 72 |
PSEUDOMONAL BACTERAEMIA |
2 |
0.0023 |
| 73 |
AMYLOIDOSIS |
4 |
0.0023 |
| 74 |
SERUM FERRITIN DECREASED |
4 |
0.0023 |
| 75 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
17 |
0.0023 |
| 76 |
MENINGOENCEPHALITIS HERPETIC |
1 |
0.0022 |
| 77 |
PNEUMONIA VIRAL |
7 |
0.0022 |
| 78 |
HYPERMETROPIA |
2 |
0.0021 |
| 79 |
HYPERGAMMAGLOBULINAEMIA |
1 |
0.0021 |
| 80 |
IMMUNODEFICIENCY COMMON VARIABLE |
1 |
0.0020 |
| 81 |
MASTOIDITIS |
2 |
0.0020 |
| 82 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
9 |
0.0020 |
| 83 |
HYPOHIDROSIS |
1 |
0.0020 |
| 84 |
BONE EROSION |
7 |
0.0020 |
| 85 |
OSTEOPENIA |
30 |
0.0020 |
| 86 |
DISSEMINATED TUBERCULOSIS |
5 |
0.0019 |
| 87 |
CAROTID ARTERIOSCLEROSIS |
2 |
0.0019 |
| 88 |
POLYCYTHAEMIA |
4 |
0.0019 |
| 89 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
5 |
0.0019 |
| 90 |
NON-ALCOHOLIC STEATOHEPATITIS |
2 |
0.0019 |
| 91 |
ENTEROCOCCAL INFECTION |
9 |
0.0019 |
| 92 |
BLOOD GASES ABNORMAL |
1 |
0.0019 |
| 93 |
DIFFUSE LARGE B-CELL LYMPHOMA |
14 |
0.0018 |
| 94 |
REPETITIVE SPEECH |
1 |
0.0018 |
| 95 |
HYPERTRIGLYCERIDAEMIA |
10 |
0.0017 |
| 96 |
IRREGULAR BREATHING |
1 |
0.0017 |
| 97 |
DROP ATTACKS |
1 |
0.0017 |
| 98 |
HEPATIC STEATOSIS |
31 |
0.0017 |
| 99 |
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED |
2 |
0.0016 |
| 100 |
SYSTEMIC CANDIDA |
4 |
0.0016 |
| 101 |
TRACHEO-OESOPHAGEAL FISTULA |
1 |
0.0016 |
| 102 |
URINARY SEDIMENT PRESENT |
1 |
0.0016 |
| 103 |
APLASIA |
3 |
0.0015 |
| 104 |
PNEUMOTHORAX SPONTANEOUS |
1 |
0.0015 |
| 105 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
4 |
0.0014 |
| 106 |
VIRAL HAEMORRHAGIC CYSTITIS |
1 |
0.0014 |
| 107 |
NONINFECTIVE ENCEPHALITIS |
1 |
0.0014 |
| 108 |
TOXIC LEUKOENCEPHALOPATHY |
1 |
0.0014 |
| 109 |
SYMPTOM MASKED |
1 |
0.0014 |
| 110 |
BRAIN STEM SYNDROME |
1 |
0.0013 |
| 111 |
ASTIGMATISM |
2 |
0.0013 |
| 112 |
MALIGNANT ASCITES |
1 |
0.0013 |
| 113 |
FUNGAEMIA |
2 |
0.0013 |
| 114 |
SUPERINFECTION BACTERIAL |
1 |
0.0013 |
| 115 |
HAPTOGLOBIN DECREASED |
1 |
0.0012 |
| 116 |
POLYCYTHAEMIA VERA |
1 |
0.0012 |
| 117 |
CEREBRAL VENOUS SINUS THROMBOSIS |
1 |
0.0012 |
| 118 |
HEPATOSPLENOMEGALY |
3 |
0.0012 |
| 119 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
4 |
0.0012 |
| 120 |
MALIGNANT HYPERTENSION |
1 |
0.0012 |
| 121 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
3 |
0.0011 |
| 122 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
33 |
0.0011 |
| 123 |
CYTOMEGALOVIRUS VIRAEMIA |
5 |
0.0011 |
| 124 |
URINARY TRACT INFECTION ENTEROCOCCAL |
1 |
0.0011 |
| 125 |
FRACTURE |
20 |
0.0011 |
| 126 |
HYPERCHOLESTEROLAEMIA |
10 |
0.0010 |
| 127 |
DEVICE RELATED THROMBOSIS |
1 |
0.0010 |
| 128 |
INFLAMMATORY MARKER INCREASED |
5 |
0.0010 |
| 129 |
MUCOSAL DISORDER |
1 |
0.0010 |
| 130 |
SKIN OEDEMA |
1 |
0.0010 |
| 131 |
AUTONOMIC NEUROPATHY |
1 |
0.0010 |
| 132 |
SUSPECTED PRODUCT CONTAMINATION |
1 |
0.0010 |
| 133 |
DEMYELINATING POLYNEUROPATHY |
1 |
0.0010 |
| 134 |
CONSCIOUSNESS FLUCTUATING |
1 |
0.0010 |
| 135 |
EXOPHTHALMOS |
2 |
0.0009 |
| 136 |
AMAUROSIS FUGAX |
1 |
0.0009 |
| 137 |
STREPTOCOCCAL BACTERAEMIA |
1 |
0.0009 |
| 138 |
PRODUCT NAME CONFUSION |
1 |
0.0009 |
| 139 |
RETROPERITONEAL HAEMATOMA |
2 |
0.0009 |
| 140 |
EMBOLIC STROKE |
3 |
0.0009 |
| 141 |
HYPORESPONSIVE TO STIMULI |
1 |
0.0009 |
| 142 |
FIBRIN D DIMER INCREASED |
3 |
0.0008 |
| 143 |
CLOSTRIDIUM COLITIS |
1 |
0.0008 |
| 144 |
CEREBRAL ARTERY EMBOLISM |
1 |
0.0008 |
| 145 |
SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT |
1 |
0.0008 |
| 146 |
HOSTILITY |
2 |
0.0008 |
| 147 |
BLOOD BILIRUBIN ABNORMAL |
1 |
0.0008 |
| 148 |
BRONCHOPULMONARY ASPERGILLOSIS |
6 |
0.0008 |
| 149 |
MUCORMYCOSIS |
2 |
0.0008 |
| 150 |
EXFOLIATIVE RASH |
2 |
0.0008 |
| 151 |
MENINGITIS VIRAL |
1 |
0.0007 |
| 152 |
NEPHROPATHY TOXIC |
8 |
0.0007 |
| 153 |
NECK MASS |
2 |
0.0007 |
| 154 |
RESPIRATORY SYMPTOM |
2 |
0.0007 |
| 155 |
CEREBELLAR HAEMORRHAGE |
1 |
0.0007 |
| 156 |
RENAL INFARCT |
1 |
0.0007 |
| 157 |
STAPHYLOCOCCAL BACTERAEMIA |
3 |
0.0007 |
| 158 |
MUTISM |
1 |
0.0007 |
| 159 |
PULMONARY SEPSIS |
1 |
0.0007 |
| 160 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
19 |
0.0007 |
| 161 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
1 |
0.0007 |
| 162 |
HAEMOGLOBIN INCREASED |
3 |
0.0007 |
| 163 |
ISCHAEMIA |
3 |
0.0007 |
| 164 |
LOSS OF THERAPEUTIC RESPONSE |
2 |
0.0006 |
| 165 |
STRONGYLOIDIASIS |
1 |
0.0006 |
| 166 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
3 |
0.0006 |
| 167 |
PUPIL FIXED |
1 |
0.0006 |
| 168 |
SOFT TISSUE INFECTION |
1 |
0.0005 |
| 169 |
CATARACT |
32 |
0.0005 |
| 170 |
ENCEPHALOPATHY |
13 |
0.0005 |
| 171 |
HUMAN HERPESVIRUS 6 INFECTION |
1 |
0.0005 |
| 172 |
BLOOD BICARBONATE DECREASED |
1 |
0.0005 |
| 173 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
5 |
0.0005 |
| 174 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
2 |
0.0005 |
| 175 |
OPTIC ISCHAEMIC NEUROPATHY |
2 |
0.0005 |
| 176 |
NEUROTOXICITY |
9 |
0.0005 |
| 177 |
HEPATOMEGALY |
5 |
0.0005 |
| 178 |
MULTI-ORGAN DISORDER |
1 |
0.0005 |
| 179 |
PNEUMONIA FUNGAL |
2 |
0.0005 |
| 180 |
PNEUMONIA STAPHYLOCOCCAL |
1 |
0.0005 |
| 181 |
BACTERAEMIA |
6 |
0.0005 |
| 182 |
CELL DEATH |
1 |
0.0005 |
| 183 |
SMALL INTESTINAL HAEMORRHAGE |
1 |
0.0005 |
| 184 |
ORGAN FAILURE |
2 |
0.0005 |
| 185 |
CYTOPENIA |
6 |
0.0005 |
| 186 |
EXTRAVASATION |
2 |
0.0005 |
| 187 |
NEUTROPENIC COLITIS |
1 |
0.0005 |
| 188 |
WALKING DISABILITY |
1 |
0.0005 |
| 189 |
LUNG ABSCESS |
1 |
0.0005 |
| 190 |
PSEUDOMONAS INFECTION |
4 |
0.0005 |
| 191 |
HYPERPHOSPHATAEMIA |
1 |
0.0005 |
| 192 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
8 |
0.0005 |
| 193 |
DISTRIBUTIVE SHOCK |
1 |
0.0004 |
| 194 |
HAEMATOCRIT INCREASED |
1 |
0.0004 |
| 195 |
PANCREATITIS NECROTISING |
1 |
0.0004 |
| 196 |
SINUS PAIN |
1 |
0.0004 |
| 197 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
11 |
0.0004 |
| 198 |
SPLENOMEGALY |
5 |
0.0004 |
| 199 |
DISSEMINATED INTRAVASCULAR COAGULATION |
6 |
0.0004 |
| 200 |
DISTURBANCE IN SOCIAL BEHAVIOUR |
1 |
0.0004 |
| 201 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0004 |
| 202 |
INTRA-ABDOMINAL HAEMORRHAGE |
1 |
0.0004 |
| 203 |
RENAL DISORDER |
19 |
0.0004 |
| 204 |
EYE OEDEMA |
1 |
0.0004 |
| 205 |
RETROPERITONEAL HAEMORRHAGE |
1 |
0.0004 |
| 206 |
HYPERNATRAEMIA |
2 |
0.0004 |
| 207 |
NEUTROPHIL COUNT INCREASED |
4 |
0.0004 |
| 208 |
ABNORMAL UTERINE BLEEDING |
1 |
0.0004 |
| 209 |
PRODUCT PREPARATION ERROR |
8 |
0.0004 |
| 210 |
CEREBRAL ISCHAEMIA |
2 |
0.0004 |
| 211 |
PERIORBITAL OEDEMA |
2 |
0.0004 |
| 212 |
PULMONARY HAEMORRHAGE |
3 |
0.0004 |
| 213 |
MUCOSAL INFLAMMATION |
10 |
0.0004 |
| 214 |
AREFLEXIA |
1 |
0.0004 |
| 215 |
NEOPLASM PROGRESSION |
13 |
0.0004 |
| 216 |
BRADYPNOEA |
1 |
0.0004 |
| 217 |
FOOT FRACTURE |
7 |
0.0004 |
| 218 |
ACUTE RESPIRATORY FAILURE |
7 |
0.0004 |
| 219 |
CYTOMEGALOVIRUS INFECTION |
6 |
0.0004 |
| 220 |
MYELOSUPPRESSION |
13 |
0.0004 |
| 221 |
LYMPHOPENIA |
5 |
0.0004 |
| 222 |
VITAMIN B12 DECREASED |
1 |
0.0003 |
| 223 |
PERIPHERAL SENSORY NEUROPATHY |
2 |
0.0003 |
| 224 |
DISEASE PROGRESSION |
40 |
0.0003 |
| 225 |
PLEURISY |
2 |
0.0003 |
| 226 |
BRAIN HERNIATION |
1 |
0.0003 |
| 227 |
METABOLIC ENCEPHALOPATHY |
1 |
0.0003 |
| 228 |
EMERGENCY CARE |
1 |
0.0003 |
| 229 |
ARTHROPATHY |
18 |
0.0003 |
| 230 |
BRAIN DEATH |
1 |
0.0003 |
| 231 |
GENERALISED OEDEMA |
4 |
0.0003 |
| 232 |
AGRANULOCYTOSIS |
6 |
0.0003 |
| 233 |
ELECTROENCEPHALOGRAM ABNORMAL |
1 |
0.0003 |
| 234 |
HEPATITIS B REACTIVATION |
1 |
0.0003 |
| 235 |
HAEMOGLOBIN ABNORMAL |
2 |
0.0003 |
| 236 |
THROMBOTIC MICROANGIOPATHY |
3 |
0.0003 |
| 237 |
RENAL TUBULAR NECROSIS |
3 |
0.0003 |
| 238 |
PRODUCT PREPARATION ISSUE |
2 |
0.0003 |
| 239 |
ASPERGILLUS INFECTION |
2 |
0.0003 |
| 240 |
OTITIS MEDIA |
1 |
0.0003 |
| 241 |
BRAIN INJURY |
3 |
0.0003 |
| 242 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
3 |
0.0003 |
| 243 |
SEPTIC SHOCK |
13 |
0.0003 |
| 244 |
LEFT VENTRICULAR DYSFUNCTION |
2 |
0.0003 |
| 245 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 246 |
ENCEPHALITIS |
2 |
0.0003 |
| 247 |
CAROTID ARTERY STENOSIS |
1 |
0.0003 |
| 248 |
VENTRICULAR ARRHYTHMIA |
1 |
0.0003 |
| 249 |
MOUTH HAEMORRHAGE |
2 |
0.0003 |
| 250 |
ASCITES |
8 |
0.0003 |
| 251 |
PULMONARY MASS |
4 |
0.0003 |
| 252 |
LEUKOENCEPHALOPATHY |
1 |
0.0003 |
| 253 |
HEPATIC NECROSIS |
1 |
0.0003 |
| 254 |
HAEMODYNAMIC INSTABILITY |
2 |
0.0003 |
| 255 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
14 |
0.0003 |
| 256 |
LYMPHADENOPATHY |
9 |
0.0003 |
| 257 |
COVID-19 PNEUMONIA |
3 |
0.0003 |
| 258 |
FURUNCLE |
2 |
0.0003 |
| 259 |
RENAL CYST |
2 |
0.0003 |
| 260 |
HYPERURICAEMIA |
1 |
0.0002 |
| 261 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 262 |
GASTROINTESTINAL PERFORATION |
1 |
0.0002 |
| 263 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
0.0002 |
| 264 |
HEPATIC CYTOLYSIS |
3 |
0.0002 |
| 265 |
PULMONARY TUBERCULOSIS |
1 |
0.0002 |
| 266 |
LIVER FUNCTION TEST INCREASED |
5 |
0.0002 |
| 267 |
METASTATIC NEOPLASM |
1 |
0.0002 |
| 268 |
DYSPHEMIA |
1 |
0.0002 |
| 269 |
TUMOUR LYSIS SYNDROME |
2 |
0.0002 |
| 270 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 271 |
ANAL INCONTINENCE |
2 |
0.0002 |
| 272 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 273 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 274 |
SHOCK |
5 |
0.0002 |
| 275 |
BACTERIAL INFECTION |
4 |
0.0002 |
| 276 |
STAPHYLOCOCCAL INFECTION |
7 |
0.0002 |
| 277 |
HYPERTENSION |
44 |
0.0002 |
| 278 |
HAEMORRHOIDAL HAEMORRHAGE |
1 |
0.0002 |
| 279 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 280 |
ORGANISING PNEUMONIA |
1 |
0.0002 |
| 281 |
TOXIC EPIDERMAL NECROLYSIS |
3 |
0.0002 |
| 282 |
CACHEXIA |
1 |
0.0002 |
| 283 |
HYPERBILIRUBINAEMIA |
2 |
0.0002 |
| 284 |
SKIN NECROSIS |
1 |
0.0002 |
| 285 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 286 |
C-REACTIVE PROTEIN INCREASED |
7 |
0.0002 |
| 287 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 288 |
SERUM FERRITIN INCREASED |
1 |
0.0002 |
| 289 |
CLOSTRIDIUM DIFFICILE COLITIS |
2 |
0.0002 |
| 290 |
NORMAL NEWBORN |
1 |
0.0002 |
| 291 |
STEVENS-JOHNSON SYNDROME |
4 |
0.0002 |
| 292 |
PLASMA CELL MYELOMA |
7 |
0.0002 |
| 293 |
PANCYTOPENIA |
10 |
0.0002 |
| 294 |
MALNUTRITION |
2 |
0.0002 |
| 295 |
ANGIOPATHY |
1 |
0.0002 |
| 296 |
INTESTINAL PERFORATION |
2 |
0.0002 |
| 297 |
MYOCARDITIS |
2 |
0.0002 |
| 298 |
PERICARDIAL EFFUSION |
4 |
0.0002 |
| 299 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
0.0002 |
| 300 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 301 |
LEUKOCYTOSIS |
3 |
0.0002 |
| 302 |
LOCALISED INFECTION |
4 |
0.0002 |
| 303 |
PLEURAL EFFUSION |
10 |
0.0002 |
| 304 |
LUNG DISORDER |
8 |
0.0002 |
| 305 |
INJECTION SITE EXTRAVASATION |
2 |
0.0002 |
| 306 |
OFF LABEL USE |
140 |
0.0002 |
| 307 |
BRAIN OEDEMA |
2 |
0.0002 |
| 308 |
WHITE BLOOD CELL COUNT ABNORMAL |
1 |
0.0002 |
| 309 |
INTRAOCULAR PRESSURE INCREASED |
2 |
0.0002 |
| 310 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 311 |
NIGHT SWEATS |
5 |
0.0002 |
| 312 |
ANAPHYLACTIC SHOCK |
4 |
0.0002 |
| 313 |
HERPES SIMPLEX |
1 |
0.0002 |
| 314 |
NODULE |
2 |
0.0002 |
| 315 |
NEPHROLITHIASIS |
7 |
0.0002 |
| 316 |
THROMBOCYTOPENIA |
17 |
0.0002 |
| 317 |
WALKING AID USER |
1 |
0.0002 |
| 318 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 319 |
ACUTE KIDNEY INJURY |
23 |
0.0002 |
| 320 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 321 |
BONE MARROW FAILURE |
3 |
0.0001 |
| 322 |
NEUTROPHIL COUNT DECREASED |
6 |
0.0001 |
| 323 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 324 |
EXTRASYSTOLES |
1 |
0.0001 |
| 325 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 326 |
GRAFT VERSUS HOST DISEASE |
1 |
0.0001 |
| 327 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 328 |
RESPIRATORY FAILURE |
10 |
0.0001 |
| 329 |
SENSITIVE SKIN |
1 |
0.0001 |
| 330 |
CARDIOMYOPATHY |
2 |
0.0001 |
| 331 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 332 |
RASH MACULO-PAPULAR |
3 |
0.0001 |
| 333 |
IMMUNODEFICIENCY |
2 |
0.0001 |
| 334 |
SUNBURN |
1 |
0.0001 |
| 335 |
HAEMOLYSIS |
1 |
0.0001 |
| 336 |
EJECTION FRACTION DECREASED |
2 |
0.0001 |
| 337 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 338 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 339 |
MUSCLE DISORDER |
1 |
0.0001 |
| 340 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 341 |
CARDIAC ARREST |
10 |
0.0001 |
| 342 |
EMBOLISM |
1 |
0.0001 |
| 343 |
BLOOD UREA INCREASED |
2 |
0.0001 |
| 344 |
HAEMODIALYSIS |
1 |
0.0001 |
| 345 |
CANDIDA INFECTION |
2 |
0.0001 |
| 346 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 347 |
SEPSIS |
13 |
0.0001 |
| 348 |
MYOPATHY |
1 |
0.0001 |
| 349 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 350 |
ARTHRITIS |
9 |
0.0001 |
| 351 |
HYPERKALAEMIA |
4 |
0.0001 |
| 352 |
HYPOXIA |
4 |
0.0001 |
| 353 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 354 |
LUNG INFILTRATION |
1 |
0.0001 |
| 355 |
PLATELET COUNT DECREASED |
12 |
0.0001 |
| 356 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
4 |
0.0001 |
| 357 |
HIDRADENITIS |
1 |
0.0001 |
| 358 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 359 |
PRODUCT USE IN UNAPPROVED INDICATION |
27 |
0.0001 |
| 360 |
UROSEPSIS |
1 |
0.0001 |
| 361 |
CONJUNCTIVITIS |
2 |
0.0001 |
| 362 |
HAEMOPTYSIS |
3 |
0.0001 |
| 363 |
HEPATIC FUNCTION ABNORMAL |
4 |
0.0001 |
| 364 |
FLANK PAIN |
1 |
0.0001 |
| 365 |
LACERATION |
1 |
0.0001 |
| 366 |
INFUSION RELATED REACTION |
7 |
0.0001 |
| 367 |
PROTEINURIA |
2 |
0.0001 |
| 368 |
NEUROPATHY PERIPHERAL |
10 |
0.0001 |
| 369 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 370 |
CHOLESTASIS |
2 |
0.0001 |
| 371 |
AFFECT LABILITY |
1 |
0.0001 |
| 372 |
THERAPY CHANGE |
1 |
0.0001 |
| 373 |
HEPATIC FAILURE |
3 |
0.0001 |
| 374 |
HYPOTHERMIA |
1 |
0.0001 |
| 375 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 376 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 377 |
CARDIAC DISORDER |
9 |
0.0001 |
| 378 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 379 |
TOXICITY TO VARIOUS AGENTS |
16 |
0.0001 |
| 380 |
PULMONARY EMBOLISM |
9 |
0.0001 |
| 381 |
LACTIC ACIDOSIS |
3 |
0.0001 |
| 382 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 383 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 384 |
CLOSTRIDIUM DIFFICILE INFECTION |
2 |
0.0001 |
| 385 |
WOUND INFECTION |
1 |
0.0001 |
| 386 |
NERVE INJURY |
1 |
0.0001 |
| 387 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 388 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 389 |
ORAL PAIN |
2 |
0.0001 |
| 390 |
THERAPY NON-RESPONDER |
4 |
0.0001 |
| 391 |
PANCREATITIS ACUTE |
2 |
0.0001 |
| 392 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 393 |
HEART RATE IRREGULAR |
2 |
0.0001 |
| 394 |
NEUTROPENIA |
12 |
0.0001 |
| 395 |
SCAB |
1 |
0.0001 |
| 396 |
COVID-19 |
15 |
0.0001 |
| 397 |
MYOCLONUS |
1 |
0.0001 |
| 398 |
CEREBRAL HAEMORRHAGE |
3 |
0.0001 |
| 399 |
RASH ERYTHEMATOUS |
4 |
0.0001 |
| 400 |
POLYNEUROPATHY |
1 |
0.0001 |
| 401 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 402 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 403 |
CARDIOMEGALY |
1 |
0.0001 |
| 404 |
ILEUS |
1 |
0.0001 |
| 405 |
LEUKOPENIA |
4 |
0.0001 |
| 406 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 407 |
CONDITION AGGRAVATED |
24 |
0.0001 |
| 408 |
DRUG DOSE OMISSION |
13 |
0.0001 |
| 409 |
HYPOPHAGIA |
2 |
0.0001 |
| 410 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 411 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 412 |
BLOOD CREATININE INCREASED |
5 |
0.0001 |
| 413 |
SEDATION |
2 |
0.0001 |
| 414 |
WEIGHT INCREASED |
17 |
0.0001 |
| 415 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 416 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 417 |
DISORIENTATION |
3 |
0.0001 |
| 418 |
ADVERSE REACTION |
1 |
0.0001 |
| 419 |
FEBRILE NEUTROPENIA |
5 |
0.0001 |
| 420 |
HYPOTENSION |
15 |
0.0001 |
| 421 |
DRUG INEFFECTIVE |
98 |
0.0001 |
| 422 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 423 |
RESPIRATORY DISTRESS |
2 |
0.0001 |
| 424 |
MASS |
1 |
0.0001 |
| 425 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 426 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
5 |
0.0001 |
| 427 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 428 |
BRONCHOSPASM |
1 |
0.0001 |
| 429 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 430 |
FLUID OVERLOAD |
1 |
0.0001 |
| 431 |
RENAL FAILURE |
9 |
0.0001 |
| 432 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 433 |
TACHYCARDIA |
6 |
0.0001 |
| 434 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 435 |
APHASIA |
2 |
0.0001 |
| 436 |
OEDEMA PERIPHERAL |
8 |
0.0001 |
| 437 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 438 |
UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 439 |
LYMPHOMA |
1 |
0.0001 |
| 440 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 441 |
BLOOD CHOLESTEROL INCREASED |
3 |
0.0001 |
| 442 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 443 |
NERVOUS SYSTEM DISORDER |
2 |
0.0001 |
| 444 |
CYANOSIS |
1 |
0.0001 |
| 445 |
DISEASE RECURRENCE |
3 |
0.0001 |
| 446 |
PNEUMONIA |
20 |
0.0001 |
| 447 |
ATRIAL FIBRILLATION |
6 |
0.0001 |
| 448 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 449 |
FUNGAL INFECTION |
2 |
0.0001 |
| 450 |
GASTROINTESTINAL HAEMORRHAGE |
5 |
0.0001 |
| 451 |
RENAL IMPAIRMENT |
5 |
0.0001 |
| 452 |
HAEMATURIA |
2 |
0.0001 |
| 453 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 454 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 455 |
DELIRIUM |
2 |
0.0001 |
| 456 |
INTENTIONAL PRODUCT USE ISSUE |
5 |
0.0001 |
| 457 |
PANCREATITIS |
3 |
0.0001 |
| 458 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 459 |
BRADYCARDIA |
3 |
0.0001 |
| 460 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 461 |
OEDEMA |
3 |
0.0001 |
| 462 |
TOOTHACHE |
1 |
0.0001 |
| 463 |
OSTEOMYELITIS |
1 |
0.0001 |
| 464 |
AGITATION |
4 |
0.0001 |
| 465 |
HYPERSENSITIVITY |
10 |
0.0001 |
| 466 |
THINKING ABNORMAL |
1 |
0.0001 |
| 467 |
DYSARTHRIA |
2 |
0.0001 |
| 468 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 469 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 470 |
COLITIS |
2 |
0.0001 |
| 471 |
GASTRIC ULCER |
1 |
0.0001 |
| 472 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 473 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
| 474 |
PYREXIA |
18 |
0.0001 |
| 475 |
DYSTONIA |
1 |
0.0001 |
| 476 |
BONE PAIN |
3 |
0.0001 |
| 477 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 478 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 479 |
SPINAL FRACTURE |
1 |
0.0000 |
| 480 |
CARDIAC FAILURE |
4 |
0.0000 |
| 481 |
STOMATITIS |
3 |
0.0000 |
| 482 |
ILL-DEFINED DISORDER |
3 |
0.0000 |
| 483 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 484 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 485 |
MELAENA |
1 |
0.0000 |
| 486 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 487 |
GASTROINTESTINAL DISORDER |
4 |
0.0000 |
| 488 |
ADVERSE DRUG REACTION |
4 |
0.0000 |
| 489 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 490 |
DEATH |
37 |
0.0000 |
| 491 |
SWELLING |
4 |
0.0000 |
| 492 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
3 |
0.0000 |
| 493 |
COMA |
2 |
0.0000 |
| 494 |
PRESYNCOPE |
1 |
0.0000 |
| 495 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 496 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 497 |
SOMNOLENCE |
8 |
0.0000 |
| 498 |
CELLULITIS |
2 |
0.0000 |
| 499 |
HAEMATEMESIS |
1 |
0.0000 |
| 500 |
FLUID RETENTION |
2 |
0.0000 |
| 501 |
HEPATITIS |
1 |
0.0000 |
| 502 |
MALIGNANT NEOPLASM PROGRESSION |
4 |
0.0000 |
| 503 |
ERECTILE DYSFUNCTION |
1 |
0.0000 |
| 504 |
INFLAMMATION |
2 |
0.0000 |
| 505 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 506 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 507 |
THROMBOSIS |
3 |
0.0000 |
| 508 |
JAUNDICE |
1 |
0.0000 |
| 509 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 510 |
RASH PRURITIC |
2 |
0.0000 |
| 511 |
PALLOR |
1 |
0.0000 |
| 512 |
TREATMENT FAILURE |
3 |
0.0000 |
| 513 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 514 |
HYPONATRAEMIA |
2 |
0.0000 |
| 515 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 516 |
HYPERSOMNIA |
1 |
0.0000 |
| 517 |
HERPES ZOSTER |
2 |
0.0000 |
| 518 |
SEIZURE |
4 |
0.0000 |
| 519 |
INFECTION |
5 |
0.0000 |
| 520 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 521 |
ADVERSE EVENT |
3 |
0.0000 |
| 522 |
CHEST PAIN |
6 |
0.0000 |
| 523 |
ANAEMIA |
6 |
0.0000 |
| 524 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 525 |
VIRAL INFECTION |
1 |
0.0000 |
| 526 |
DEHYDRATION |
4 |
0.0000 |
| 527 |
RASH |
13 |
0.0000 |
| 528 |
FLUSHING |
3 |
0.0000 |
| 529 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 530 |
VISION BLURRED |
4 |
0.0000 |
| 531 |
RASH MACULAR |
1 |
0.0000 |
| 532 |
WHITE BLOOD CELL COUNT DECREASED |
3 |
0.0000 |
| 533 |
NO ADVERSE EVENT |
5 |
0.0000 |
| 534 |
RESTLESSNESS |
1 |
0.0000 |
| 535 |
DYSGEUSIA |
2 |
0.0000 |
| 536 |
EYE SWELLING |
1 |
0.0000 |
| 537 |
PRODUCT USE ISSUE |
5 |
0.0000 |
| 538 |
HALLUCINATION |
2 |
0.0000 |
| 539 |
GENERAL PHYSICAL HEALTH DETERIORATION |
3 |
0.0000 |
| 540 |
PARAESTHESIA |
4 |
0.0000 |
| 541 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 542 |
DYSKINESIA |
1 |
0.0000 |
| 543 |
FATIGUE |
19 |
0.0000 |
| 544 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 545 |
MYALGIA |
4 |
0.0000 |
| 546 |
ANGIOEDEMA |
1 |
0.0000 |
| 547 |
LIVER DISORDER |
1 |
0.0000 |
| 548 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 549 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 550 |
TINNITUS |
1 |
0.0000 |
| 551 |
BACK PAIN |
5 |
0.0000 |
| 552 |
VOMITING |
10 |
0.0000 |
| 553 |
DYSPNOEA |
12 |
0.0000 |
| 554 |
ARRHYTHMIA |
1 |
0.0000 |
| 555 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 556 |
PAIN IN EXTREMITY |
6 |
0.0000 |
| 557 |
DYSPEPSIA |
2 |
0.0000 |
| 558 |
DRY EYE |
1 |
0.0000 |
| 559 |
ARTHRALGIA |
8 |
0.0000 |
| 560 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 561 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 562 |
SPEECH DISORDER |
1 |
0.0000 |
| 563 |
DIARRHOEA |
12 |
0.0000 |
| 564 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 565 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 566 |
MEDICATION ERROR |
1 |
0.0000 |
| 567 |
NECK PAIN |
1 |
0.0000 |
| 568 |
BLISTER |
1 |
0.0000 |
| 569 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 570 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 571 |
LETHARGY |
1 |
0.0000 |
| 572 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 573 |
IRRITABILITY |
1 |
0.0000 |
| 574 |
FEELING HOT |
1 |
0.0000 |
| 575 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 576 |
ASTHENIA |
6 |
0.0000 |
| 577 |
HYPERHIDROSIS |
2 |
0.0000 |
| 578 |
AMNESIA |
1 |
0.0000 |
| 579 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 580 |
NAUSEA |
12 |
0.0000 |
| 581 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 582 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 583 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 584 |
BURNING SENSATION |
1 |
0.0000 |
| 585 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 586 |
MOBILITY DECREASED |
1 |
0.0000 |
| 587 |
UNDERDOSE |
1 |
0.0000 |
| 588 |
BRONCHITIS |
1 |
0.0000 |
| 589 |
EPISTAXIS |
1 |
0.0000 |
| 590 |
HYPOAESTHESIA |
2 |
0.0000 |
| 591 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 592 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 593 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 594 |
HOSPITALISATION |
2 |
0.0000 |
| 595 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 596 |
DECREASED APPETITE |
3 |
0.0000 |
| 597 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 598 |
MALAISE |
5 |
0.0000 |
| 599 |
PAIN |
7 |
0.0000 |
| 600 |
INSOMNIA |
3 |
0.0000 |
| 601 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 602 |
MUSCLE SPASMS |
2 |
0.0000 |
| 603 |
ANXIETY |
3 |
0.0000 |
| 604 |
DYSPHAGIA |
1 |
0.0000 |
| 605 |
MIGRAINE |
1 |
0.0000 |
| 606 |
PRURITUS |
4 |
0.0000 |
| 607 |
CONTUSION |
1 |
0.0000 |
| 608 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 609 |
PRODUCT DOSE OMISSION ISSUE |
3 |
0.0000 |
| 610 |
HEART RATE INCREASED |
1 |
0.0000 |
| 611 |
SYNCOPE |
1 |
0.0000 |
| 612 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 613 |
ILLNESS |
1 |
0.0000 |
| 614 |
HEADACHE |
6 |
0.0000 |
| 615 |
HAEMORRHAGE |
1 |
0.0000 |
| 616 |
CONSTIPATION |
2 |
0.0000 |
| 617 |
INFLUENZA |
1 |
0.0000 |
| 618 |
PALPITATIONS |
1 |
0.0000 |
| 619 |
CHILLS |
1 |
0.0000 |
| 620 |
FEELING ABNORMAL |
2 |
0.0000 |
| 621 |
JOINT SWELLING |
1 |
0.0000 |
| 622 |
DIZZINESS |
4 |
0.0000 |
| 623 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 624 |
PSORIASIS |
1 |
0.0000 |
| 625 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 626 |
WEIGHT DECREASED |
2 |
0.0000 |
| 627 |
COUGH |
2 |
0.0000 |
| 628 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 629 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 630 |
URTICARIA |
1 |
0.0000 |
| 631 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 632 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 633 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 634 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 635 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 636 |
ALOPECIA |
1 |
0.0000 |
| 637 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 638 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 639 |
OVERDOSE |
1 |
0.0000 |
| 640 |
DEPRESSION |
1 |
0.0000 |
| 641 |
FALL |
1 |
0.0000 |